Latest News
Clarke Companies Acquires Covex to Enhance Manufacturing and Operations for FDA Customers
Tuesday 14 January 2020

14 January 2020 - Indiana-based The Clarke Companies, a provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry has added Covex, LLC, to its portfolio of businesses, to expand services in biopharma and medical device markets, the company said.
Terms of the transaction were not disclosed.
The combined organisation leverages Clarke's engineering pedigree in FDA regulated services in manufacturing and packaging with Covex's strengths in the Enterprise IT stack, including computer systems validation, to provide a more connected, cohesive, and compliant IT, manufacturing and software systems environment.
The expanded, connected platform will better serve its regulated Life Sciences customers as FDA regulations drive the convergence of enterprise IT with manufacturing and operations.
The Covex acquisition was led by private equity sponsor Lightview Capital, which originally invested in Clarke in 2015, and Maranon Capital, which provided debt financing.
The acquisition doubles the size of The Clarke Companies, expands its geographic footprint and extends the roster of talent available to its clients.
In addition, the synergies of the combined companies will deliver more value to its client base with Covex's proven track record in quality management system consulting, compliance, IT validation and computer systems validation.
The Clarke Companies include Clarke Solutions, Acquire Automation and Covex, LLC. Clarke Solutions is a professional services firm, providing engineering, automation and validation services to enable clients to automate, validate, optimise and maintain life sciences products and manufacturing.
Acquire Automation is an automation solutions provider specialising in machine vision systems and automation to monitor every product, package and label for maximum quality to eliminate recalls.
Covex, LLC, provides global validation and compliance services for the life sciences, food and beverage and chemical industries. Covex offers systems validation, regulatory compliance, engineering and IT services as an end-to-end solution.
Lightview Capital is a private equity firm focussed on providing its portfolio companies deep industry knowledge, insightful experience, and active resources to unlock growth and drive value.
Date Published: 14/01/2020
Target: Covex, LLC
Country: USA
Sector: Pharmaceuticals
Type: Corporate acquisition
Status: Closed
Buyer: The Clarke Companies
Terms of the deal were not disclosed